Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stock Holdings Reduced by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. cut its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 132,926 shares of the pharmacy operator’s stock after selling 9,445 shares during the period. Rockefeller Capital Management L.P.’s holdings in Walgreens Boots Alliance were worth $1,193,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in WBA. Charles Schwab Investment Management Inc. lifted its stake in shares of Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after purchasing an additional 3,329,857 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Walgreens Boots Alliance by 12.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock valued at $68,046,000 after buying an additional 817,762 shares in the last quarter. Thompson Siegel & Walmsley LLC lifted its position in shares of Walgreens Boots Alliance by 15.5% in the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after buying an additional 934,754 shares during the last quarter. FMR LLC boosted its stake in shares of Walgreens Boots Alliance by 2.5% during the 3rd quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator’s stock worth $29,200,000 after acquiring an additional 80,525 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. increased its holdings in shares of Walgreens Boots Alliance by 6.1% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,718,659 shares of the pharmacy operator’s stock valued at $32,882,000 after acquiring an additional 156,484 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Up 1.1 %

Shares of WBA stock opened at $8.56 on Monday. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $27.05. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. The stock has a fifty day moving average price of $9.16 and a 200 day moving average price of $10.89. The stock has a market cap of $7.40 billion, a P/E ratio of -0.86, a price-to-earnings-growth ratio of 1.12 and a beta of 0.66.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. During the same period last year, the firm earned $0.67 EPS. The firm’s revenue for the quarter was up 5.9% compared to the same quarter last year. Analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a $0.25 dividend. The ex-dividend date is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.68%. Walgreens Boots Alliance’s payout ratio is presently -9.99%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on WBA. JPMorgan Chase & Co. decreased their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. UBS Group upped their price objective on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Royal Bank of Canada lowered their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a research note on Wednesday, December 4th. Evercore ISI boosted their target price on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 16th. Finally, TD Cowen lowered their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, October 22nd. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus target price of $12.58.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.